Specifically, these TAM subpopulations may preferentially secrete specific cytokines (e.g., IL-10 from CD163+HMOX1+ microglia) to induce immunosuppression, and targeting these cytokines and their relevant molecular pathways holds great therapeutic potential in GBM (20, 59). This evidence concerns the gene CD163 and glioblastoma.